VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEUTSCHE BANK AG\ | 42,476 | $398,000 | 0.00% |
| Amundi | 10,863 | $90,923 | 0.00% |
| Allspring Global Investments Holdings, LLC | 9,157 | $85,801 | 0.00% |
| Bell Investment Advisors, Inc | 27 | $253 | 0.00% |
| Geneos Wealth Management Inc. | 60 | $562 | 0.00% |
| UBS ASSET MANAGEMENT AMERICAS INC | 80,414 | $753,478 | 0.00% |
| HSBC HOLDINGS PLC | 16,071 | $150,907 | 0.00% |
| VOYA INVESTMENT MANAGEMENT LLC | 33,532 | $314,195 | 0.00% |
| Lindbrook Capital, LLC | 428 | $4,010 | 0.00% |
| JANE STREET GROUP, LLC | 28,461 | $266,680 | 0.00% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 63,057 | $590,844 | 0.00% |
| Prestige Wealth Management Group LLC | 31 | $291 | 0.00% |
| BANK OF MONTREAL /CAN/ | 15,391 | $151,447 | 0.00% |
| JFS WEALTH ADVISORS, LLC | 1 | $10 | 0.00% |
| Allworth Financial LP | 3,823 | $35,822 | 0.00% |
External links
This page lists VIR BIOTECHNOLOGY INC's shareholders in Q3 2023. To view VIR BIOTECHNOLOGY INC's shareholder history, click here.